Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Work In Process: 2016-2024

  • Zepp Health's Work In Process fell 50.41% to $5.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 million, marking a year-over-year decrease of 50.41%. This contributed to the annual value of $5.3 million for FY2024, which is 50.41% down from last year.
  • Per Zepp Health's latest filing, its Work In Process stood at $5.3 million for Q4 2024, which was down 50.41% from $10.6 million recorded in Q4 2023.
  • Over the past 5 years, Zepp Health's Work In Process peaked at $35.2 million during Q4 2020, and registered a low of $5.3 million during Q4 2024.
  • Moreover, its 3-year median value for Work In Process was $10.6 million (2023), whereas its average is $11.4 million.
  • As far as peak fluctuations go, Zepp Health's Work In Process soared by 40.63% in 2020, and later slumped by 50.41% in 2024.
  • Zepp Health's Work In Process (Quarterly) stood at $35.2 million in 2020, then declined by 0.46% to $35.0 million in 2021, then plummeted by 47.62% to $18.4 million in 2022, then crashed by 42.15% to $10.6 million in 2023, then crashed by 50.41% to $5.3 million in 2024.
  • Its last three reported values are $5.3 million in Q4 2024, $10.6 million for Q4 2023, and $18.4 million during Q4 2022.